The Characterization of Biotherapeutics & Vaccines pipeline features three back-to-back popular conferences on critical topics such as analytical and characterization tools for protein aggregation, stability assessment, detection, and control of contaminants and impurities in biotherapeutics and vaccines for covid-19 and other diseases. These conferences will feature case studies, new and unpublished data, interactive discussions, panel discussions on strategies and tools for characterization, risk assessment, and mitigation for protein aggregates, particles, and impurities arising from products, excipients, processes, and packaging in novel biologics and vaccines and mRNA therapies.

 

January 16-17

Characterization of Biotherapeutics

January 17-18

Characterizing Protein Aggregates and Impurities

January 19-20

Characterization and Development of Vaccines


If you are working in the following areas join the PepTalk community: 

  • Analytical Development
  • BioProcess Development
  • Formulation development
  • Late-Stage Development
  • Manufacturing
  • Mass Spectrometry
  • Material Sciences
  • New Product Development
  • Pharmaceutics
  • Pharmaceutical Development
  • Pharmaceutical R&D
  • Process Development/Control/Support
  • Process & Product Development
  • (New) Product Development
  • Process Engineering
  • Protein Analytics
  • Protein Analytical Chemistry
  • Purification and Process Development
  • QA/QC
  • Research & Development


Submit a Speaker Proposal

View By: